Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Lido di Camaiore
Clinical trial register · Italy

Clinical Trials in Lido di Camaiore, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6778 matching records held by the registry are in this view. Synced 08 Oct 2026, 03:19 UTC
6778
Studies in scope
all four open statuses
4069
Recruiting now
open to new participants
1018
Lead sponsors
across recruiting studies
Top sites
Milan 2843 Bologna 1305 Roma 1274 Naples 984 Rome 967
Narrow the registerReset
Recruitment status
Phase
Site location
Milan2843 Bologna1305 Roma1274 Naples984 Rome967
All 489 locations
Target enrolment
to

Trials with a site in Lido di Camaiore

10 of 6778 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Recruiting
Pulmonary Embolism Registry From Short-Term Emergency to Long-Term Follow-Up and Surveillance
NCT07855679Venous Thromboembolism (VTE), Chronic Thromboembolic Pulmonary Hypertension, Right Ventricular Dysfunction, Pulmonary Embolism (PE)
Azienda Ospedaliero-Universitaria Careggi
Observational
5,000
Bagno a Ripoli, Borgo San Lorenzo, Empoli, Florence, Pescia, Pistoia, Prato, Lido di Camaiore
2026-06-19
Not yet open
Gruppo Oncologico Italiano di Ricerca Clinica
Phase 2
108
Bologna, Cuneo, Meldola, Cona, Lido di Camaiore, Lucca, Mantua, Pisa
2026-05
Recruiting
Gruppo Oncologico Italiano di Ricerca Clinica
Observational
50
Bari, Meldola, Ferrara, Genova, Lido di Camaiore, Lucca, Monza, Milan
2025-08-12
Recruiting
Gruppo Oncologico Italiano di Ricerca Clinica
Phase 2
142
Aviano (PN), Bari, Bologna, Carpi, Cremona, Cuneo, Florence, Lido di Camaiore
2025-01-24
Recruiting
Centro di Riferimento Oncologico - Aviano
Phase 2
45
Aviano, Florence, Lido di Camaiore, Meldola, Monza, Padova, Parma, Perugia
2024-03-15
Active, closed
Ascendis Pharma Oncology Division A/S
Phase 1/2
320
Cuneo, Florence, Grosseto, Lido di Camaiore, Livorno, Meldola, Milan, Modena
2022-01-11
Active, closed
Mirati Therapeutics Inc.
Phase 3
461
Avellino, Biella, Cagliari, Candiolo, Lido di Camaiore, Meldola, Milan, Naples
2021-06-24
Active, closed
Alectinib in Neo-adjuvant Treatment of Stage III NSCLC
NCT05015010Non Small Cell Lung Cancer
Gruppo Oncologico Italiano di Ricerca Clinica
Phase 2
33
Meldola, Lido di Camaiore, Monza, Aviano, Orbassano, Bari, Bologna, Catania
2021-05-20
Recruiting
Use of EBPT in Critically Ill Patients With AKI and/or Multiorgan Failure
NCT04033224Critical Illness, Acute Kidney Injury, Sepsis, Systemic Inflammatory Response Syndrome
Careggi Hospital
Observational
1,000
Empoli, Lido di Camaiore, Rozzano, San Donato Milanese, Monza, Brindisi, Florence, Pavia
2019-07-16
Recruiting
PREgnancy and FERtility Registry
NCT02895165Breast Neoplasms, Pregnancy, Fertility Preservation
IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy
Observational
1,000
Asti, Brindisi, Monserrato, Cuneo, Cona, Genoa, Lecce, Lido di Camaiore
2012-11
Rows per page Showing 1–10 of 10
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 9 October 2026. https://priyalifescience.com/clinical-trials-italy/city/lido-di-camaiore

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,778 studies in total at the last sync on 08 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 10 of those studies with a site in Lido di Camaiore.

How many clinical trials are recruiting in Lido di Camaiore?

6 of the 10 studies on this page are recruiting new participants as of the 08 Oct 2026, 03:19 UTC sync. A further 1 have not yet opened recruitment, 3 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Lido di Camaiore), 10 studies
PhaseStudiesRecruitingShare
Observational4440%
Phase 24240%
Phase 1/21010%
Phase 31010%

Most active sponsors

Lead sponsors with the most studies (Lido di Camaiore)
Lead sponsorStudiesRecruiting
Gruppo Oncologico Italiano di Ricerca Clinica42
Ascendis Pharma Oncology Division A/S10
Azienda Ospedaliero-Universitaria Careggi11
Careggi Hospital11
Centro di Riferimento Oncologico - Aviano11
IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy11
Mirati Therapeutics Inc.10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.